Clinical Topics

Articles

People with hypertension who adhered to the mobile app demonstrated well-controlled blood pressure over a 12-week observational period. 

Smartphone App Shows Promise for Managing Hypertension in Observational Study

Donna H. Ryan, MD, is professor emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, and past president of The Obesity Society.

Videos

Donna Ryan, MD, discusses the most significant clinical trials published this year in the field of obesity medicine.

Pivotal Obesity Trials in 2024: A Conversation with Donna Ryan, MD

Your daily dose of the clinical news you may have missed.

More than Half of US Adults Eligible for Semaglutide: Daily Dose

Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose

New Trial Backs Intensive Blood Pressure Target for Adults with T2D: Daily Dose

 focuses on pitfalls in emergency medicine such as confusing a cause with a coincidence, being falsely reassured by false negative tests, or getting burned by illogical assumptions. 

We hope to improve the care you provide your patients and keep you from being an honored guest at your department’s next peer review meeting. 

 or searching “EM Logic” on Apple podcast or “Pregerson” on Spotify.

Dr Pregerson has been practicing emergency medicine since 2000, lecturing and writing about medical topics since 2004, and has reviewed more than 180 malpractice cases since 2008. He is the author of 3 EM pocket references, the creator of 

If you would like to be considered as a guest on a future episode, contact Dr. Pregerson at Safetydoc@gmail.com.

A woman in her early 50s presents with 6 hours of right sided pleuritic chest pain. What do the history and ECG suggest? What's yoru Dx?

Right-Sided Chest Pain, Elevated HR: Seen in the ED 

The patient shows no signs of trauma but is a poor historian so no further details are available. Do her vitals or ECG provide any clues to a Dx?  

Middle-Aged Women Found Down: Seen in the ED 

GLP-1RAs, SGLT2is Cut Risk of Future MI, Stroke in Survivors: Daily Dose

US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose

Millions of US adults could benefit from semaglutide treatment for diabetes, obesity, and/or CV disease but insurance isn't guaranteed and the drug is costly.  

Cardiology